154 related articles for article (PubMed ID: 38157642)
1. Macrophage fatty acid oxidation in atherosclerosis.
Xiao S; Qi M; Zhou Q; Gong H; Wei D; Wang G; Feng Q; Wang Z; Liu Z; Zhou Y; Ma X
Biomed Pharmacother; 2024 Jan; 170():116092. PubMed ID: 38157642
[TBL] [Abstract][Full Text] [Related]
2. Macrophage fatty acid oxidation and its roles in macrophage polarization and fatty acid-induced inflammation.
Namgaladze D; Brüne B
Biochim Biophys Acta; 2016 Nov; 1861(11):1796-1807. PubMed ID: 27614008
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activation.
Hohensinner PJ; Lenz M; Haider P; Mayer J; Richter M; Kaun C; Goederle L; Brekalo M; Salzmann M; Sharma S; Fischer MB; Stojkovic S; Ramsmayer D; Hengstenberg C; Podesser BK; Huber K; Binder CJ; Wojta J; Speidl WS
Biochem Pharmacol; 2021 Aug; 190():114634. PubMed ID: 34058186
[TBL] [Abstract][Full Text] [Related]
4. Macrophage fatty acid oxidation inhibits atherosclerosis progression.
Nomura M; Liu J; Yu ZX; Yamazaki T; Yan Y; Kawagishi H; Rovira II; Liu C; Wolfgang MJ; Mukouyama YS; Finkel T
J Mol Cell Cardiol; 2019 Feb; 127():270-276. PubMed ID: 30639412
[TBL] [Abstract][Full Text] [Related]
5. AMPK promotes macrophage fatty acid oxidative metabolism to mitigate inflammation: implications for diabetes and cardiovascular disease.
Steinberg GR; Schertzer JD
Immunol Cell Biol; 2014 Apr; 92(4):340-5. PubMed ID: 24638063
[TBL] [Abstract][Full Text] [Related]
6. S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation.
Liu S; Zhang H; Li Y; Zhang Y; Bian Y; Zeng Y; Yao X; Wan J; Chen X; Li J; Wang Z; Qin Z
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145030
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid oxidation is dispensable for human macrophage IL-4-induced polarization.
Namgaladze D; Brüne B
Biochim Biophys Acta; 2014 Sep; 1841(9):1329-35. PubMed ID: 24960101
[TBL] [Abstract][Full Text] [Related]
8. NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages.
Moon JS; Nakahira K; Chung KP; DeNicola GM; Koo MJ; Pabón MA; Rooney KT; Yoon JH; Ryter SW; Stout-Delgado H; Choi AM
Nat Med; 2016 Sep; 22(9):1002-12. PubMed ID: 27455510
[TBL] [Abstract][Full Text] [Related]
9. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease.
Tontonoz P; Nagy L
Curr Opin Lipidol; 1999 Dec; 10(6):485-90. PubMed ID: 10680041
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function.
Chinetti G; Fruchart JC; Staels B
Curr Opin Lipidol; 2003 Oct; 14(5):459-68. PubMed ID: 14501584
[TBL] [Abstract][Full Text] [Related]
11. Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation.
Malandrino MI; Fucho R; Weber M; Calderon-Dominguez M; Mir JF; Valcarcel L; Escoté X; Gómez-Serrano M; Peral B; Salvadó L; Fernández-Veledo S; Casals N; Vázquez-Carrera M; Villarroya F; Vendrell JJ; Serra D; Herrero L
Am J Physiol Endocrinol Metab; 2015 May; 308(9):E756-69. PubMed ID: 25714670
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of macrophage fatty acid β-oxidation exacerbates palmitate-induced inflammatory and endoplasmic reticulum stress responses.
Namgaladze D; Lips S; Leiker TJ; Murphy RC; Ekroos K; Ferreiros N; Geisslinger G; Brüne B
Diabetologia; 2014 May; 57(5):1067-77. PubMed ID: 24488024
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid oxidation contributes to IL-1β secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration.
Zhang Q; Wang H; Mao C; Sun M; Dominah G; Chen L; Zhuang Z
Mol Immunol; 2018 Feb; 94():27-35. PubMed ID: 29248877
[TBL] [Abstract][Full Text] [Related]
14. Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis.
Zhang X; McDonald JG; Aryal B; Canfrán-Duque A; Goldberg EL; Araldi E; Ding W; Fan Y; Thompson BM; Singh AK; Li Q; Tellides G; Ordovás-Montanes J; García Milian R; Dixit VD; Ikonen E; Suárez Y; Fernández-Hernando C
Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782454
[TBL] [Abstract][Full Text] [Related]
15. AICAR inhibits PPARγ during monocyte differentiation to attenuate inflammatory responses to atherogenic lipids.
Namgaladze D; Kemmerer M; von Knethen A; Brüne B
Cardiovasc Res; 2013 Jun; 98(3):479-87. PubMed ID: 23531513
[TBL] [Abstract][Full Text] [Related]
16. Nuclear receptors in macrophages: a link between metabolism and inflammation.
Szanto A; Roszer T
FEBS Lett; 2008 Jan; 582(1):106-16. PubMed ID: 18022390
[TBL] [Abstract][Full Text] [Related]
17. A long noncoding RNA regulates inflammation resolution by mouse macrophages through fatty acid oxidation activation.
Nakayama Y; Fujiu K; Yuki R; Oishi Y; Morioka MS; Isagawa T; Matsuda J; Oshima T; Matsubara T; Sugita J; Kudo F; Kaneda A; Endo Y; Nakayama T; Nagai R; Komuro I; Manabe I
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14365-14375. PubMed ID: 32513690
[TBL] [Abstract][Full Text] [Related]
18. Monocyte and macrophage immunometabolism in atherosclerosis.
Groh L; Keating ST; Joosten LAB; Netea MG; Riksen NP
Semin Immunopathol; 2018 Feb; 40(2):203-214. PubMed ID: 28971272
[TBL] [Abstract][Full Text] [Related]
19. PPARβ in macrophages and atherosclerosis.
Chinetti-Gbaguidi G; Staels B
Biochimie; 2017 May; 136():59-64. PubMed ID: 28011212
[TBL] [Abstract][Full Text] [Related]
20. Activation of peroxisome proliferator-activated receptor δ inhibits human macrophage foam cell formation and the inflammatory response induced by very low-density lipoprotein.
Bojic LA; Sawyez CG; Telford DE; Edwards JY; Hegele RA; Huff MW
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2919-28. PubMed ID: 23023367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
